Zisook S

Department of Psychiatry, University of California San Diego, San Diego, CA, United States.

7 papers · 1 preprint

ArticlePsilocybin

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.

Goodwin GM, Aaronson ST, Alvarez O +23

Europe PMC2026
ArticlePsilocybin

Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].

Goodwin GM, Aaronson ST, Alvarez O +28

Europe PMC2026
ArticlePsychedelics

Should we skip the trip? Clinical implications of psychedelic-associated subjective effects and the potential role of non-hallucinogenic alternatives.

Bhatt KV, Asuncion JD, Alam A +2

Europe PMC2025
ArticlePsilocybin

The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.

Goodwin GM, Aaronson ST, Alvarez O +28

Europe PMC2025
ArticlePsilocybin

Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.

Dougherty RF, Clarke P, Atli M +10

Europe PMC2025
ArticleKetamine

Pharmacologic Approaches to Suicide Prevention.

Zisook S, Domingues I, Compton J

Europe PMC2023
PreprintPsilocybin

Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing

Dougherty RF, Clarke P, Alti M +10

Europe PMC2022
ArticleKetamine

How do serotonergic psychedelics treat depression: The potential role of neuroplasticity.

Artin H, Zisook S, Ramanathan D

Europe PMC2021